[Advances in superenzyme gene therapy in penile rehabilitation].
Zhonghua Nan Ke Xue
; 19(4): 350-4, 2013 Apr.
Article
de Zh
| MEDLINE
| ID: mdl-23678717
ABSTRACT
Erectile dysfunction (ED) is an almost unavoidable complication of radical prostatectomy. At present, though the concept of penile rehabilitation (PR) is accepted by most clinicians, the outcomes of erectile function recovery vary widely. Prostacyclin (PGI2) is a prostanoid and a main vasoprotectant which induces smooth muscle relaxation, but not used for replacement therapy because of its high unstability. SuperEnzyme is capable of continuous, specific and targeted promotion of PGI2 synthesis, and helps PR in ED patients after radical prostatectomy. SuperEnzyme gene therapy has a promising prospect for PR and the management of ED. This review updates SuperEnzyme gene therapy in PR.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Thérapie génétique
/
Dysfonctionnement érectile
Limites:
Humans
/
Male
Langue:
Zh
Journal:
Zhonghua Nan Ke Xue
Sujet du journal:
MEDICINA REPRODUTIVA
Année:
2013
Type de document:
Article
Pays d'affiliation:
Chine